EEVIA HEALTH OYJ |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.45 SEK | -5.84% |
|
-18.99% | +38.10% |
| Apr. 26 | Finland’s Eevia Health Lands Repeat Order from Swedish Client | MT |
| Apr. 26 | Eevia Health plc Receives A SEK 590K (EUR 51K) Repeat Sales Order | CI |
Valuation
| Fiscal Period: December | 2021 | 2022 |
|---|---|---|
| Capitalization 1 | 12.34 | 2.446 |
| Enterprise Value (EV) 1 | 11.03 | 2.79 |
| P/E ratio | -5.36 x | -2.28 x |
| Yield | - | - |
| Capitalization / Revenue | 1.81 x | 0.42 x |
| EV / Revenue | 1.62 x | 0.48 x |
| EV / EBITDA | -5,253,760 x | -3,019,131 x |
| EV / FCF | - | -984,137 x |
| FCF Yield | - | -0% |
| Price to Book | 4.04 x | 1.38 x |
| Nbr of stocks (in thousands) | 13,952 | 15,973 |
| Reference price 2 | 0.8844 | 0.1531 |
| Announcement Date | 5/31/22 | 6/13/23 |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net sales 1 | 0.799 | 1.321 | 1.404 | 2.928 | 6.808 | 5.763 |
| EBITDA | - | -0.6641 | -0.2548 | -0.6938 | -2.1 | -0.9242 |
| EBIT 1 | -0.6359 | -0.8127 | -0.3689 | -0.9229 | -2.59 | -1.474 |
| Operating Margin | -79.58% | -61.52% | -26.27% | -31.52% | -38.04% | -25.58% |
| Earnings before Tax (EBT) 1 | -0.6405 | -0.8348 | -0.4073 | -1.023 | -2.636 | -2.043 |
| Net income 1 | -0.6405 | -0.8348 | -0.4073 | -1.023 | -2.636 | -2.043 |
| Net margin | -80.16% | -63.19% | -29% | -34.95% | -38.71% | -35.44% |
| EPS | - | -0.1670 | - | - | -0.1650 | -0.0673 |
| Free Cash Flow | - | - | - | - | - | -2.835 |
| FCF margin | - | - | - | - | - | -49.19% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 8/15/18 | 8/15/19 | 8/15/20 | 5/10/21 | 5/31/22 | 6/13/23 |
1EUR in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | 0.34 |
| Net Cash position 1 | 0.03 | 0.11 | 0.58 | 0.51 | 1.31 | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | -0.3724 x |
| Free Cash Flow | - | - | - | - | - | -2.84 |
| ROE (net income / shareholders' equity) | - | -283% | -48.6% | -109% | -134% | -59.5% |
| ROA (Net income/ Total Assets) | - | -57.8% | -16.1% | -13.9% | -21.7% | -11.6% |
| Assets 1 | - | 1.445 | 2.531 | 7.37 | 12.17 | 17.59 |
| Book Value Per Share 2 | 0.0700 | 0.0400 | - | - | 0.2200 | 0.1100 |
| Cash Flow per Share 2 | 0.0100 | 0.0200 | - | - | 0.1200 | 0.0200 |
| Capex | - | - | - | - | - | 0.85 |
| Capex / Sales | - | - | - | - | - | 14.83% |
| Announcement Date | 8/15/18 | 8/15/19 | 8/15/20 | 5/10/21 | 5/31/22 | 6/13/23 |
1EUR in Million2EUR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- EEVIA Stock
- Financials Eevia Health Oyj
